Atlas Trials

Postmarketing Clinical Study on AO-128

Clinical trial NCT02287402 · COMPLETED

Trial details

NCT number
NCT02287402
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Impaired Glucose Tolerance (IGT)
Start date
2010-03-01
Primary completion
2012-11-01
Enrollment
197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.